Skip to Content
Merck
CN

Vitamin C epigenetically controls osteogenesis and bone mineralization.

Nature communications (2022-10-07)
Roman Thaler, Farzaneh Khani, Ines Sturmlechner, Sharareh S Dehghani, Janet M Denbeigh, Xianhu Zhou, Oksana Pichurin, Amel Dudakovic, Sofia S Jerez, Jian Zhong, Jeong-Heon Lee, Ramesh Natarajan, Ivo Kalajzic, Yong-Hui Jiang, David R Deyle, Eleftherios P Paschalis, Barbara M Misof, Tamas Ordog, Andre J van Wijnen
ABSTRACT

Vitamin C deficiency disrupts the integrity of connective tissues including bone. For decades this function has been primarily attributed to Vitamin C as a cofactor for collagen maturation. Here, we demonstrate that Vitamin C epigenetically orchestrates osteogenic differentiation and function by modulating chromatin accessibility and priming transcriptional activity. Vitamin C regulates histone demethylation (H3K9me3 and H3K27me3) and promotes TET-mediated 5hmC DNA hydroxymethylation at promoters, enhancers and super-enhancers near bone-specific genes. This epigenetic circuit licenses osteoblastogenesis by permitting the expression of all major pro-osteogenic genes. Osteogenic cell differentiation is strictly and continuously dependent on Vitamin C, whereas Vitamin C is dispensable for adipogenesis. Importantly, deletion of 5hmC-writers, Tet1 and Tet2, in Vitamin C-sufficient murine bone causes severe skeletal defects which mimic bone phenotypes of Vitamin C-insufficient Gulo knockout mice, a model of Vitamin C deficiency and scurvy. Thus, Vitamin C's epigenetic functions are central to osteoblastogenesis and bone formation and may be leveraged to prevent common bone-degenerating conditions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-5-Formylcytosine (5fC) Antibody, clone EDL FC-5, clone EDL FC-5, from mouse
Sigma-Aldrich
Anti-Histone H3 Antibody, 0.5 mg/mL, Upstate®